{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:20:04Z","timestamp":1790014804493,"version":"4.0.1"},"reference-count":43,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003685","name":"KLI","doi-asserted-by":"publisher","award":["1015"],"award-info":[{"award-number":["1015"]}],"id":[{"id":"10.13039\/501100003685","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Growth hormone (GH) reduces intrahepatic lipids (IHL) according to investigations in healthy volunteers and patients with acromegaly, a disease characterized by long-term GH excess.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study investigated underlying antisteatotic pathways stimulated by short-term modulation of GH action.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ten healthy male volunteers (26 \u00b1 5 years, body mass index [BMI] 23 \u00b1 3.4\u2005kg\/m2) were assessed before and after 1 week of daily subcutaneous treatment with either GH or a GH-receptor antagonist in a crossover study (EK Nr.1395\/2020; Eudra-CT:2020-000831-34). The assessments comprised the quantification of IHL and hepatic ATP synthesis via magnetic resonance spectroscopy, assessment of very low-density lipoprotein (VLDL) secretion by an intralipid infusion protocol, and measurement of de novo lipogenesis (DNL) using stable isotope tracer techniques. In comparison, effects of long-term GH excess on VLDL secretion were investigated in patients with active acromegaly (54 \u00b1 5 years; BMI 29.3 \u00b1 3.6\u2005kg\/m2; insulin-like growth factor I of 3.1 \u00b1 1 \u00d7 upper limit of normal).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>GH treatment stimulated the secretion of VLDL-triglycerides by 26.1% (590.5 \u00b1 282.3\u2005mg\/h vs 738.8 \u00b1 424.9\u2005mg\/h, P = .035). Contrarily, mean DNL doubled after GH-receptor blockage without statistical significance (3.06 \u00b1 1.95 vs 7.32 \u00b1 8.43%, P = .107). Effects on hepatic ATP synthesis were not observed. Baseline hepatic VLDL secretion was comparable between volunteers and patients with acromegaly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GH modulates hepatic lipid turnover via an increase in hepatic triglyceride export and repressed GH action tends to foster DNL, which may be of assistance for the development of future therapeutic strategies against metabolic dysfunction\u2013associated steatotic liver disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf155","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T07:36:25Z","timestamp":1744270585000},"page":"3420-3429","source":"Crossref","is-referenced-by-count":6,"title":["Growth Hormone Promotes Hepatic Triglyceride Export in Humans"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5277-4011","authenticated-orcid":false,"given":"Clemens","family":"Baumgartner","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8344-9799","authenticated-orcid":false,"given":"Matth\u00e4us","family":"Metz","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Beghini","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Pfleger","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tosin","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Koldyka","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6542-5737","authenticated-orcid":false,"given":"Hannes","family":"Beiglb\u00f6ck","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7970-0971","authenticated-orcid":false,"given":"Paul","family":"Fellinger","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-1959","authenticated-orcid":false,"given":"Greisa","family":"Vila","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Luger","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3520-4105","authenticated-orcid":false,"given":"Alexandra","family":"Kautzky-Willer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Freudenthaler","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Baumgartner-Parzer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Stangl","sequence":"additional","affiliation":[{"name":"Center for Pathobiochemistry and Genetics, Medical University of Vienna, Institute of Medical Chemistry , Waehringer Stra\u00dfe 10, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Krssak","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]},{"name":"Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, High-Field MR Centre, Lazarettgasse 14 , Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Carli","sequence":"additional","affiliation":[{"name":"Cardiometabolic Risk Unit, Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche (CNR) , Via Giuseppe Moruzzi 1, Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Infelise","sequence":"additional","affiliation":[{"name":"Cardiometabolic Risk Unit, Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche (CNR) , Via Giuseppe Moruzzi 1, Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2594-1651","authenticated-orcid":false,"given":"Amalia","family":"Gastaldelli","sequence":"additional","affiliation":[{"name":"Cardiometabolic Risk Unit, Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche (CNR) , Via Giuseppe Moruzzi 1, Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4980-706X","authenticated-orcid":false,"given":"Thomas","family":"Scherer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9265-7274","authenticated-orcid":false,"given":"Michael","family":"Krebs","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6779-734X","authenticated-orcid":false,"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III , Waehringer Guertel 18-20, Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"12","key":"2025111718530167700_dgaf155-B1","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat Metab"},{"issue":"3","key":"2025111718530167700_dgaf155-B2","doi-asserted-by":"crossref","first-page":"e13695","DOI":"10.1111\/eci.13695","article-title":"Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis","volume":"52","author":"Guerra","year":"2022","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"2025111718530167700_dgaf155-B3","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"issue":"3","key":"2025111718530167700_dgaf155-B4","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin Invest"},{"issue":"9","key":"2025111718530167700_dgaf155-B5","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1194\/jlr.D600044-JLR200","article-title":"Development of a novel method to determine very low density lipoprotein kinetics","volume":"48","author":"Al-Shayji","year":"2007","journal-title":"J Lipid Res"},{"issue":"11","key":"2025111718530167700_dgaf155-B6","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.cmet.2022.09.020","article-title":"Leptin increases hepatic triglyceride export via a vagal mechanism in humans","volume":"34","author":"Metz","year":"2022","journal-title":"Cell Metab"},{"issue":"4","key":"2025111718530167700_dgaf155-B7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"issue":"5","key":"2025111718530167700_dgaf155-B8","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","volume":"76","author":"Moore","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"2025111718530167700_dgaf155-B9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"2025111718530167700_dgaf155-B10","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"issue":"7785","key":"2025111718530167700_dgaf155-B11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"issue":"3","key":"2025111718530167700_dgaf155-B12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J Hepatol"},{"issue":"3","key":"2025111718530167700_dgaf155-B13","doi-asserted-by":"crossref","first-page":"e00030","DOI":"10.1097\/IN9.0000000000000030","article-title":"Growth hormone and nonalcoholic fatty liver disease","volume":"5","author":"Ma","year":"2023","journal-title":"Immunometabolism"},{"issue":"7","key":"2025111718530167700_dgaf155-B14","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1210\/clinem\/dgac088","article-title":"Growth hormone and insulin-like growth factor 1 regulation of nonalcoholic fatty liver disease","volume":"107","author":"Dichtel","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025111718530167700_dgaf155-B15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"M\u00f8ller","year":"2009","journal-title":"Endocr Rev"},{"issue":"2","key":"2025111718530167700_dgaf155-B16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/EJE-21-0900","article-title":"Treatment of acromegaly has substantial effects on body composition: a long-term follow-up study","volume":"186","author":"Wolf","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2025111718530167700_dgaf155-B17","doi-asserted-by":"crossref","first-page":"e989","DOI":"10.1210\/clinem\/dgad206","article-title":"Increased GH\/IGF-I axis activity relates to lower hepatic lipids and phosphor metabolism","volume":"108","author":"Fellinger","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025111718530167700_dgaf155-B18","doi-asserted-by":"crossref","first-page":"e134638","DOI":"10.1172\/jci.insight.134638","article-title":"Increased ATP synthesis might counteract hepatic lipid accumulation in acromegaly","volume":"5","author":"Fellinger","year":"2020","journal-title":"JCI Insight"},{"issue":"11","key":"2025111718530167700_dgaf155-B19","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2014-2242","article-title":"No evidence of ectopic lipid accumulation in the pathophysiology of the acromegalic cardiomyopathy","volume":"99","author":"Winhofer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025111718530167700_dgaf155-B20","doi-asserted-by":"crossref","first-page":"e1542","DOI":"10.1210\/clinem\/dgad375","article-title":"Growth hormone administration improves nonalcoholic fatty liver disease in overweight\/obesity: a randomized trial","volume":"108","author":"Dichtel","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025111718530167700_dgaf155-B21","doi-asserted-by":"crossref","first-page":"102089","DOI":"10.1016\/j.xpro.2023.102089","article-title":"Measuring VLDL1 secretion in humans with an intravenous fat emulsion test","volume":"4","author":"Metz","year":"2023","journal-title":"STAR Protoc"},{"issue":"2","key":"2025111718530167700_dgaf155-B22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jmri.26225","article-title":"Absolute quantification of phosphor-containing metabolites in the liver using 31 P MRSI and hepatic lipid volume correction at 7T suggests no dependence on body mass index or age","volume":"49","author":"Pfleger","year":"2019","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"2025111718530167700_dgaf155-B23","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1007\/s00330-014-3141-x","article-title":"Application of localized 31P MRS saturation transfer at 7T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver disease","volume":"24","author":"Valkovi\u010d","year":"2014","journal-title":"Eur Radiol"},{"issue":"5","key":"2025111718530167700_dgaf155-B24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/nbm.1207","article-title":"Quantitative ATP synthesis in human liver measured by localized 31P spectroscopy using the magnetization transfer experiment","volume":"21","author":"Schmid","year":"2008","journal-title":"NMR Biomed"},{"issue":"10","key":"2025111718530167700_dgaf155-B25","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/nbm.3382","article-title":"Ultrashort-TE stimulated echo acquisition mode (STEAM) improves the quantification of lipids and fatty acid chain unsaturation in the human liver at 7T","volume":"28","author":"Gajdo\u0161\u00edk","year":"2015","journal-title":"NMR Biomed"},{"key":"2025111718530167700_dgaf155-B26","unstructured":"Baumgartner C, Wolf P. 2025. Supplementary data for \u201cGrowth hormone promotes hepatic triglyceride export in humans\u201d. Figshare. doi:10.6084\/M9.FIGSHARE.28498007. 113627 Bytes."},{"issue":"6","key":"2025111718530167700_dgaf155-B27","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1172\/JCI111644","article-title":"Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects","volume":"74","author":"Packard","year":"1984","journal-title":"J Clin Invest"},{"issue":"8","key":"2025111718530167700_dgaf155-B28","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars","volume":"41","author":"Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"key":"2025111718530167700_dgaf155-B29","author":"Clinical Institute of Laboratory Medicine, AKH Vienna"},{"issue":"4","key":"2025111718530167700_dgaf155-B30","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1210\/jc.2003-031474","article-title":"Effects of growth hormone (GH) replacement therapy on low-density lipoprotein apolipoprotein B100 kinetics in adult patients with GH deficiency: a stable isotope study","volume":"89","author":"Christ","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025111718530167700_dgaf155-B31","doi-asserted-by":"crossref","first-page":"E920","DOI":"10.1152\/ajpendo.00374.2006","article-title":"Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics","volume":"292","author":"Krag","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"2025111718530167700_dgaf155-B32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41574-019-0256-9","article-title":"The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state","volume":"15","author":"Hodson","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2025111718530167700_dgaf155-B33","doi-asserted-by":"crossref","first-page":"E737","DOI":"10.1152\/ajpendo.00092.2003","article-title":"Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients","volume":"285","author":"N\u00f8rrelund","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2025111718530167700_dgaf155-B34","doi-asserted-by":"crossref","first-page":"155589","DOI":"10.1016\/j.metabol.2023.155589","article-title":"Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis","volume":"144","author":"V\u00e1zquez-Borrego","year":"2023","journal-title":"Metabolism"},{"issue":"9","key":"2025111718530167700_dgaf155-B35","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2337\/db15-0370","article-title":"Growth hormone inhibits hepatic de novo lipogenesis in adult mice","volume":"64","author":"Cordoba-Chacon","year":"2015","journal-title":"Diabetes"},{"key":"2025111718530167700_dgaf155-B36","doi-asserted-by":"crossref","first-page":"101332","DOI":"10.1016\/j.ghir.2020.101332","article-title":"Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppression","volume":"53\u201354","author":"Villanueva-Ortega","year":"2020","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"2025111718530167700_dgaf155-B37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"2025111718530167700_dgaf155-B38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/ajcn\/nqy304","article-title":"Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers","volume":"109","author":"Rosqvist","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"2025111718530167700_dgaf155-B39","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1210\/jc.2017-01210","article-title":"Body composition and ectopic lipid changes with biochemical control of acromegaly","volume":"102","author":"Bredella","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025111718530167700_dgaf155-B40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/db11-1718","article-title":"Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance","volume":"62","author":"Zhu","year":"2013","journal-title":"Diabetes"},{"issue":"3","key":"2025111718530167700_dgaf155-B41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00125-019-05040-3","article-title":"Sex differences in metabolic regulation and diabetes susceptibility","volume":"63","author":"Tramunt","year":"2020","journal-title":"Diabetologia"},{"issue":"24","key":"2025111718530167700_dgaf155-B42","doi-asserted-by":"crossref","first-page":"10874","DOI":"10.7150\/thno.47037","article-title":"Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD\/NASH development","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"issue":"6","key":"2025111718530167700_dgaf155-B43","first-page":"2098","article-title":"Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH","volume":"84","author":"Thorner","year":"1999","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf155\/62916339\/dgaf155.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/12\/3420\/62916339\/dgaf155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/12\/3420\/62916339\/dgaf155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:53:19Z","timestamp":1763423599000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/12\/3420\/8111581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,4,11]]},"published-print":{"date-parts":[[2025,11,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf155","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,4,11]]}}}